News & Trends - Medical Technology

MedTech response to COVID-19 – ResMed, Stryker, Baxter, Boston Scientific, Zimmer and Medtronic

Health Industry Hub | May 13, 2020 |
[Total: 1    Average: 4/5]

Medical device companies are playing a critical role in supplying frontline healthcare workers with the equipment needed to fight COVID-19 while adapting to a changing economic landscape in which elective surgeries, field force interactions and supply chains have been disrupted.


The company received approval for a device to sterilise N95 masks and similar respirators. The Sterizone VP4 Steriliser is 510(k)-cleared for use in terminal sterilisation of cleaned, rinsed, and dried metal and non-metal reusable medical devices in healthcare facilities. Stryker will also produce 10,000 “low-cost, limited-release emergency response” beds per week.

Stryker is temporarily cutting CEO Kevin Lobo’s base salary in half and reducing some executives’ and board members’ salaries.


ResMed will be launching a cloud-based remote monitoring software for various ventilator models to help protect care providers from frequent exposure to sick patients. The platform, called AirView, allows care providers to track a patient’s respiratory rate and blood oxygen saturation.

Register FREE & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

Boston Scientific

Boston Scientific is producing a low-cost emergency resuscitator designed in the U.S.

Biopharma company Soligenix is licensing a novel vaccine adjuvant for SARS-CoV-2 from BTG Specialty Pharmaceuticals, a division Boston Scientific gained in its $4.2 billion takeover of BTG last year.


Baxter received approval for the Oxiris blood purification filter to reduce pro-inflammatory cytokine levels in COVID-19 patients admitted to the ICU with respiratory failure. The company plans to increase production in the coming months. Baxter is also providing dialysis machines and fluids to implement peritoneal dialysis in ICUs.


Medtronic CEO Omar Ishrak and President Geoff Martha recently called for an “unrestricted supply chain” for ventilators. “Actions by one government to restrict the global flow of needed products can lead to retaliatory actions by others. The company will not raise prices or pit one customer against another in a bidding process for these critical products.”

Medtronic is surging production of its highly acute ventilators for critically ill patients and was collaborating with Tesla’s Elon Musk on ventilator manufacturing.

Zimmer Biomet

Zimmer Biomet’s business was impacted by a significant global decline in elective procedures, a trend it expects to continue in the second quarter. Zimmer is collaborating with an industry coalition and using 3D printing to make ventilator components and face shields.

About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Leadership & Management

Leadership Management Qualities - COVID-19 wiping out hard-won gains by women in STEM

COVID-19 wiping out hard-won gains by women in STEM

Health Industry Hub | June 1, 2020 |

Hard-won gains for women’s advancement in the science, technology, engineering and maths (STEM) workforce are now at risk of a […]


News & Trends - Medical Technology

MedTech News - New agreement to end public hospitals' “harvesting” of privately insured patients

New agreement to end public hospital “harvesting” of privately insured patients

Health Industry Hub | June 1, 2020 |

MedTech News: The new National Health Reform Agreement has the potential to end the practice of public hospitals “harvesting” privately […]


News & Trends - Pharmaceuticals

Pharma News - GSK's targeted therapy for asthma gains PBS listing for self-administration delivery

GSK’s targeted therapy for asthma gains PBS listing for self-administration delivery

Health Industry Hub | June 1, 2020 |

Pharma News: From 1 June 2020, GSK Australia’s new pre-filled pen (autoinjector) for the self-administration of its targeted therapy for […]


News & Trends - Pharmaceuticals

Pharma News - Major changes to opioid PBS listings effective 1 June

Major changes to opioid PBS listings effective 1 June

Health Industry Hub | June 1, 2020 |

Commencing 1 June 2020, the Pharmaceutical Benefits Scheme (PBS) listings for opioid medicines will change including Tramal (tramadol) and Panadeine […]